| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |